Century Therapeutics, INC. (IPSC) — DEF 14A Filings

All DEF 14A filings from Century Therapeutics, INC.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (3)

Century Therapeutics Proposes Reverse Stock Split to Avoid Nasdaq Delisting — Dec 2, 2025 Risk: high
Century Therapeutics, Inc. (IPSC) is seeking stockholder approval for a reverse stock split of its common stock, with a ratio between 1-for-5 and 1-for-30, at a
Century Therapeutics Files Definitive Proxy Statement — Apr 22, 2025 Risk: low
Century Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 22, 2025, for its annual meeting on June 12, 2025. The filing concerns the so
Century Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders — Apr 26, 2024 Risk: low
Century Therapeutics, Inc. (IPSC) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. The 2024 Annual Meeting of Stockholders for Century Therapeu

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX